“Strong reasons make strong actions” — The antiviral efficacy of NS3/4A protease inhibitors†
- 1 March 2005
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Hepatology
- Vol. 41 (3) , 671-674
- https://doi.org/10.1002/hep.20610
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Convergence of the NF‐κB and Interferon Signaling Pathways in the Regulation of Antiviral Defense and ApoptosisAnnals of the New York Academy of Sciences, 2003
- An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virusNature, 2003
- Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine ProteaseScience, 2003
- Identification of the Hepatitis C Virus RNA Replication Complex in Huh-7 Cells Harboring Subgenomic RepliconsJournal of Virology, 2003
- Estimation of Early Hepatitis C Viral Clearance in Patients Receiving Daily Interferon and Ribavirin Therapy Using A Mathematical ModelHepatology, 2001
- Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virusProceedings of the National Academy of Sciences, 1999
- Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell LineScience, 1999
- Potent Peptide Inhibitors of Human Hepatitis C Virus NS3 Protease Are Obtained by Optimizing the Cleavage ProductsBiochemistry, 1998
- Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor PeptideCell, 1996
- Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis.Proceedings of the National Academy of Sciences, 1991